Despite humanity's scientific achievements and globalized economy, malnutrition remains a global issue. The United Nations ...

The US Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction ...

The new facility, FDA-approved and NABL-accredited, is designed to meet the most stringent global standards for ...

US Federal officials have approved a new pain pill by Vertex Pharmaceuticals called Journavx, aimed at reducing addiction and ...

While Tapentadol is a serious habit-forming opioid-based drug, Pregabalin has become a headache in Punjab as it is ...

Dr. Mrinal M Gounder emphasizes the complexity of breast cancer and the necessity for unique treatments for its many variants ...

Granules India's subsidiary, GPI, receives USFDA approval for Lisdexamfetamine Dimesylate Capsules, expanding ADHD treatment ...

Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.

Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.